Cannabis Investors: Can Hexo (TSX:HEXO) Stock Make a Comeback in 2021?

Will Hexo’s (TSX:HEXO) strong cannabis-infused beverage sales help drive its stock price higher in 2021?

| More on:

Another year has gone by that sees cannabis stocks underperforming the broader markets by a huge margin. Shares of Hexo (TSX:HEXO)(NYSE:HEXO) are trading at $1.37, which meant it has lost close to a quarter of its market value in 2020. Hexo stock is also trading 87% below its all-time high price.

However, since the start of November, Hexo shares have risen 70% to trade at the current price. Does this mean it can gain momentum in 2021 and continue its upward spiral?

Is Hexo stock a buy?

Hexo is a Canada-based marijuana company and recently released its fiscal fourth-quarter results (ending in July). The company reported net revenue of $27.1 million, a growth of 76% year-over-year and 23% on a sequential basis.

This stellar performance was supported by its adult-use beverages segment that accounted for $2 million in sales, up from just $431,000 in the third quarter. Hexo’s non-beverage sales also gained pace and rose by 16% to $25.1 million.

Hexo announced a joint venture with Molson Coors back in 2018 in order to gain traction in Canada’s cannabis-infused beverage market. The joint venture, Truss, launched five new brands in 2020, offering consumers multiple beverage options.

However, similar to most peer companies, Hexo is also grappling with negative profit margins. In Q4, Hexo’s net loss stood at $169.5 million, up $18.8 million year-over-year. Hexo attributed the losses to goodwill impairments and inventory write-downs.

After accounting for non-cash items, investment gains, and other adjustments, Hexo’s EBITDA loss stands at $3.3 million. Alternatively, investors should also note that the company is struggling to sell its inventory which indicates a loss in market share or lower than estimated demand.

In Q4, Hexo produced 16,540 kilograms of dried cannabis but sold just 50% of its production. This trend has been visible for close to five quarters where Hexo has consistently sold less cannabis compared to the amount it harvested. We can see why Hexo is struggling with lackluster demand and massive asset write-downs.

A major driver for Hexo stock

Marijuana stocks have gained pace in the last month after Joe Biden won the presidential race. During one of the pre-election debates, Vice President-elect Kamala Harris said the Democrats would decriminalize the use of marijuana at the federal level, which drove the pot market rally.

The legalization of cannabis south of the border will be one of the major drivers of Hexo’s stock price. This legalization may take a few years to materialize which suggests Hexo should focus on gaining market share and reducing losses in the Canadian market.

Hexo stock has a market cap of $660 million, which means its trading at a forward price to sales multiple of 4.96. Analysts also expect the company’s earnings loss to narrow from $1.77 per share in fiscal 2020 to $0.03 in fiscal 2022.

Comparatively, its sales are forecast to grow by 65% to $133.5 million in 2021 and by 30% to $173 million in 2022. We can see that Hexo is reasonably valued, especially if it can improve the bottom line and remain consistently profitable.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »